Medicare’s Open Enrollment Period in 2024 saw big changes to the Medicare Advantage market for 2025. These Medicare Advantage 2026 plans may again experience notable changes. While you might see some good news, like lower plan costs and drug savings, you may also face tough choices as insurance companies cut back on supplemental benefits.
Since the OEP (also referred to as the Annual Enrollment Period) runs from October 15 to December 7, 2025, now is the time to understand the key shifts happening in the market.
The Centers for Medicare & Medicaid Services (CMS) has released its cost projections, and they show a mixed picture for your wallet:
Premium Type | 2025 Monthly Amount (Approx.) | 2026 Monthly Projection* | The Result |
Average MA Premium | $16.40 | $14.00 | Good News: Your MA plan premium cost may decrease. |
Medicare Part B Premium | $185.00 | $206.50 | Bad News: This mandatory federal cost is expected to jump by $21.50. |
*These are current projections. The updated Medicare costs for 2026 should be announced in October.
The Catch: Even though your MA plan premium might decrease, you must still pay the Medicare Part B premium. Because the Part B cost is increasing your total monthly bill for Medicare coverage may be higher in 2026.
Insurance companies are changing their offerings to focus on profits, not just signing up new members. This will affect where and how many plans are available.
Because of the Inflation Reduction Act (IRA), new protections that started in 2025 are expanding in 2026, creating major savings for people with high prescription costs.
Drug Cost Rule | 2025 Limit | 2026 Limit | What It Means For You |
Part D Out-of-Pocket Max | $2,000 | $2,100 | You won’t pay more than this amount for covered drugs all year. |
Insulin Cost Cap | Max $35/month | Lesser of $35 or 25% of the negotiated price | Your monthly insulin costs may drop lower |
Adult Vaccines (Part D) | Deductibles/Copays may apply | $0 cost | Recommended adult vaccines (like the Shingles shot) are now completely free |
New for 2026: This is the first year that the prices for some expensive, brand-name drugs (like Eliquis, Jardiance, and Xarelto) will be lower because the government has directly negotiated them with drug manufacturers. If you take one of the affected medications, you should see a price drop.
As insurers evaluate profitability, they are looking closely at the additional benefits they offer in Medicare Advantage plans.
New Rules for “Special Benefits”: CMS is setting clear boundaries on the Special Supplemental Benefits for the Chronically Ill (SSBCI). They have now specifically outlawed things like paying for alcohol, tobacco, or general life insurance through these benefits, which limits the kind of non-medical perks plans can offer.
CMS is also stepping in to protect you from unfair denials:
More Accurate Doctor Lists: New rules require MA plans to provide more accurate lists of doctors and hospitals for the official Medicare Plan Finder. This should make it easier for you to verify your provider network.
The changes for 2026 make it vital that you review your plan during the AEP.
The Bottom Line: The MA market is in a shakeup, but doesn’t mean it’s not a viable option. While you benefit greatly from the new drug savings, you must be careful to avoid surprise costs or losing access to your doctors because of plan changes. Get ahead by doing an early, thorough review of your current plan, and the plans available in 2026.
Please log in to view assigned tenants.